Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperosmolar hyperglycemic nonketotic coma.

D W Pope1, D Dansky

  • 1Department of Emergency Medicine, Northwestern University Hospital, Chicago, Illinois.

Emergency Medicine Clinics of North America
|November 1, 1989
PubMed
Summary

Hyperosmolar hyperglycemic nonketotic coma (HHNC) is a severe condition marked by very high blood sugar levels and osmolality without ketoacidosis. It affects up to 20% of severe hyperglycemia cases and is often misdiagnosed due to its non-specific symptoms. Treatment involves aggressive intravenous fluids, potassium, and insulin, along with monitoring central venous pressure and urine output. HHNC is frequently linked to other serious diseases, which must be treated alongside the syndrome. The absence of acidosis is a key diagnostic feature. Early detection and proper management are crucial to improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Objective sleepiness measures in pediatric obstructive sleep apnea.

Pediatrics·2001
Same author

Snoring during early childhood and academic performance at ages thirteen to fourteen years.

Pediatrics·2001
Same author

Salaries in psychiatric hospitals.

The Psychiatric hospital·1990
See all related articles

Area of Science:

  • Endocrinology and metabolic disorders
  • Emergency medicine
  • Clinical management of diabetes

Background:

HHNC is a rare but severe condition marked by high blood sugar and osmolality without ketoacidosis. Prior research has shown that this syndrome affects up to 20% of severe hyperglycemia cases. It is often misdiagnosed due to its non-specific presentation and lack of acidosis. Established knowledge includes the role of hyperglycemia in causing neurological symptoms. No prior work had resolved the best approach to fluid and insulin therapy in such cases. This gap motivated further investigation into treatment protocols. The absence of clear guidelines has led to inconsistent clinical responses. Understanding the relationship between HHNC and comorbid conditions remains a challenge.

Purpose Of The Study:

This paper aims to clarify the clinical features and management of HHNC. The specific problem is the frequent misdiagnosis and inadequate treatment of this condition. The study focuses on identifying effective therapeutic interventions. The motivation stems from the high mortality rate associated with HHNC. The authors seek to emphasize the importance of early detection of underlying diseases. They aim to provide a framework for aggressive fluid and insulin therapy. The study also highlights the need for monitoring central venous pressure and urine output. The goal is to improve clinical outcomes through better understanding and treatment protocols.

Keywords:
Hyperosmolar hyperglycemic nonketotic comaSevere hyperglycemiaDiabetic emergencyClinical management

Frequently Asked Questions

HHNC lacks ketoacidosis and acidosis, whereas diabetic ketoacidosis involves elevated ketone levels and acidosis.

The authors propose that insulin is used judiciously to manage hyperglycemia in HHNC.

Monitoring central venous pressure helps guide fluid therapy in HHNC patients.

Urine output is a key indicator of hydration status and renal function in HHNC.

The study suggests that HHNC is strongly linked to other serious underlying diseases.

Related Experiment Videos

Main Methods:

The study reviews clinical data from patients diagnosed with HHNC. It involves a synthesis of existing literature on treatment approaches. The authors analyze case reports and clinical guidelines related to HHNC. They focus on the role of intravenous fluids and potassium supplementation. The study also examines the use of insulin in managing hyperglycemia. Monitoring parameters like central venous pressure and urine output are emphasized. The authors evaluate the association between HHNC and other serious conditions. The approach combines clinical observations with evidence-based recommendations.

Main Results:

The strongest finding is the high prevalence of HHNC among severe hyperglycemia cases. The study reports that up to 20% of severe hyperglycemia cases involve HHNC. Aggressive fluid therapy is shown to be a key intervention in managing the syndrome. The use of insulin is proposed as a critical component of treatment. Central venous pressure monitoring is highlighted as essential for fluid management. The study suggests that HHNC is strongly linked to other serious diseases. Patients with HHNC often have comorbid conditions that require simultaneous treatment. The absence of ketoacidosis is a distinguishing feature of HHNC compared to diabetic ketoacidosis.

Conclusions:

The authors conclude that HHNC is a life-threatening condition requiring immediate and aggressive treatment. They emphasize the importance of intravenous fluids and insulin in managing the syndrome. The study suggests that monitoring central venous pressure and urine output is crucial. The authors propose that HHNC is often associated with other serious underlying diseases. Early detection and treatment of these conditions are necessary for successful outcomes. The absence of acidosis in HHNC is a key diagnostic feature. The study highlights the need for improved clinical awareness and standardized treatment protocols. The authors suggest that further research is needed to refine management strategies.

Aggressive intravenous fluids, potassium, and insulin are the mainstays of HHNC treatment.